Alkermes PLC
Company Profile
Business description
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Contact
1 Burlington Road
Connaught House
DublinD04 C5Y6
IRLT: +353 17728000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,800
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,148.90 | 93.60 | 1.16% |
CAC 40 | 8,078.10 | 93.37 | -1.14% |
DAX 40 | 22,899.07 | 388.99 | -1.67% |
Dow JONES (US) | 41,767.38 | 197.25 | -0.47% |
FTSE 100 | 8,689.37 | 17.29 | -0.20% |
HKSE | 24,219.95 | 551.19 | -2.23% |
NASDAQ | 17,672.21 | 78.58 | -0.44% |
Nikkei 225 | 37,751.88 | 93.54 | -0.25% |
NZX 50 Index | 12,054.72 | 8.79 | 0.07% |
S&P 500 | 5,650.88 | 24.41 | -0.43% |
S&P/ASX 200 | 7,918.90 | 90.60 | 1.16% |
SSE Composite Index | 3,408.95 | 17.48 | -0.51% |